SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010050
Filing Date
2020-08-10
Accepted
2020-08-10 07:55:20
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q morf-20200630x10q.htm 10-Q 1676322
2 EX-10.1 morf-20200630ex101adfa5a.htm EX-10.1 32542
3 EX-10.2 morf-20200630ex1029ca179.htm EX-10.2 60956
4 EX-31.1 morf-20200630ex31135d9a1.htm EX-31.1 13014
5 EX-31.2 morf-20200630ex312390db8.htm EX-31.2 13546
6 EX-32.1 morf-20200630ex32180641e.htm EX-32.1 6960
7 EX-32.2 morf-20200630ex322af056e.htm EX-32.2 6348
8 GRAPHIC morf-20200630ex101adfa5a001.jpg GRAPHIC 13777
  Complete submission text file 0001558370-20-010050.txt   5789970

Data Files

Seq Description Document Type Size
9 EX-101.INS morf-20200630.xml EX-101.INS 1162641
10 EX-101.SCH morf-20200630.xsd EX-101.SCH 29313
11 EX-101.CAL morf-20200630_cal.xml EX-101.CAL 39865
12 EX-101.DEF morf-20200630_def.xml EX-101.DEF 161683
13 EX-101.LAB morf-20200630_lab.xml EX-101.LAB 349062
14 EX-101.PRE morf-20200630_pre.xml EX-101.PRE 283907
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 9787296480
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38940 | Film No.: 201087153
SIC: 2834 Pharmaceutical Preparations